Cargando…
GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice
The prevalence of obesity-related diabetes is increasing worldwide. Here we report the identification of a pentapeptide, GLP-1(32-36)amide (LVKGRamide), derived from the glucoincretin hormone GLP-1, that increases basal energy expenditure and curtails the development of obesity, insulin resistance,...
Autores principales: | Tomas, Eva, Stanojevic, Violeta, McManus, Karen, Khatri, Ashok, Everill, Paul, Bachovchin, William W., Habener, Joel F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477344/ https://www.ncbi.nlm.nih.gov/pubmed/25858562 http://dx.doi.org/10.2337/db14-1708 |
Ejemplares similares
-
GLP-1(28-36)amide, a Long Ignored Peptide Revisited
por: Zhou, Bilan, et al.
Publicado: (2014) -
Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor
por: Li, Naichang, et al.
Publicado: (2012) -
GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?
por: Taing, Meng-Wong, et al.
Publicado: (2014) -
The Gut Hormones PYY(3-36) and GLP-1(7-36 amide) Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans
por: De Silva, Akila, et al.
Publicado: (2011) -
Combination of Peptide YY(3–36) with GLP-1(7–36 amide) Causes an Increase in First-Phase Insulin Secretion after IV Glucose
por: Tan, Tricia M., et al.
Publicado: (2014)